燃石医学 (BNR.US):超额配售权获悉数行使,额外筹资 3341.25 万美元

智通财经 · 2020-06-22
燃石医学 (BNR.US) 宣布其首次公开发行的承销商已完全行使超额配售权。

智通财经 APP 获悉,6 月 22 日,燃石医学 (BNR.US) 宣布其首次公开发行的承销商已完全行使超额配售权,以每股美国存托股 16.5 美元的首次公开发行价购买公司额外的 202.5 万股美国存托股 (ADS),每股代表 1 股 A 类普通股。

全面行使超额配售权后,该公司首次公开发行以及向 Lake Bleu Prime Healthcare Master Fund Limited 私募配售的总规模约为 2.812 亿美元。全面行使超额配售权后,公司共发行普通股 (包括美国存托股代表的普通股) 总数为 103804534 股,其中 A 类普通股 86479686 股,B 类普通股 17324848 股。

Long Bridge Securities Ltd is a New Zealand registered Financial Service Provider (FSP number: FSP600050), and is a member of the Financial Dispute Resolution Scheme, a New Zealand independent dispute resolution service provider.

All data and contents of the Long Bridge website (longbridge.global) are for investors' reference only. Before conducting investment activities, investors should fully understand the relevant products, clearly know their potential risks, and make rational decisions based on their own risk tolerance; and investors should be aware that all investment activities involve risks and investment activities may not be suitable for every investor.

Customer Service Hotline:400-071-2688

0800 33 9033 / (09) 533 9033(New Zealand)

Support Email: service@longbridge.global
简体中文